Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
NVIDIA
NVDA
|
$307M |
| 2 |
Mercado Libre
MELI
|
$289M |
| 3 |
Atlassian
TEAM
|
$283M |
| 4 |
Shopify
SHOP
|
$275M |
| 5 |
Roblox
RBLX
|
$243M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$1.38B |
| 2 |
Meta Platforms (Facebook)
META
|
$565M |
| 3 |
Illumina
ILMN
|
$460M |
| 4 |
Ferrari
RACE
|
$328M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
$296M |
Sector Composition
| 1 | Healthcare | 27.94% |
| 2 | Consumer Discretionary | 24.47% |
| 3 | Technology | 18.46% |
| 4 | Communication Services | 10.28% |
| 5 | Financials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEWR
301
DELISTED
New Relic, Inc.
NEWR
| $41.4K | ﹤0.01% |
733
| – | – |
|
302
Inspire Medical Systems
INSP
$2.56B
| $40.8K | ﹤0.01% |
162
| – | – |
|
303
HubSpot
HUBS
$25.7B
| $36.4K | ﹤0.01% |
126
| – | – |
|
304
Pure Storage
PSTG
$25.9B
| $35.7K | ﹤0.01% |
1,335
| – | – |
|
305
UnitedHealth
UNH
$286B
| $35.5K | ﹤0.01% |
67
| – | – |
|
306
Amdocs
DOX
$9.46B
| $35.1K | ﹤0.01% |
386
| – | – |
|
307
Tractor Supply
TSCO
$32.1B
| $34.9K | ﹤0.01% |
775
| – | – |
|
308
Costco
COST
$427B
| $34.2K | ﹤0.01% |
75
+12
| +19% | +$5.48K |
|
309
ON Semiconductor
ON
$20.1B
| $34.2K | ﹤0.01% |
548
| – | – |
|
310
Regeneron Pharmaceuticals
REGN
$60.8B
| $33.9K | ﹤0.01% |
47
| – | – |
|
311
W.W. Grainger
GWW
$47.5B
| $33.4K | ﹤0.01% |
60
| – | – |
|
312
Bristol-Myers Squibb
BMY
$96B
| $33K | ﹤0.01% |
458
| – | – |
|
313
Celsius Holdings
CELH
$15B
| $29.3K | ﹤0.01% |
846
+84
| +11% | +$2.91K |
|
314
Toro Company
TTC
$7.99B
| $29.3K | ﹤0.01% |
259
+14
| +6% | +$1.59K |
|
315
Factset
FDS
$14B
| $28.9K | ﹤0.01% |
72
+11
| +18% | +$4.41K |
|
316
Box
BOX
$4.75B
| $28.8K | ﹤0.01% |
924
| – | – |
|
317
Visteon
VC
$3.41B
| $28.5K | ﹤0.01% |
218
| – | – |
|
|
EH
318
EHang Holdings
EH
$1.16B
| $28.4K | ﹤0.01% |
3,314
+209
| +7% | +$1.79K |
|
319
Humana
HUM
$37B
| $28.2K | ﹤0.01% |
55
| – | – |
|
320
SEI Investments
SEIC
$10.8B
| $27.5K | ﹤0.01% |
471
+62
| +15% | +$3.62K |
|
321
AstraZeneca
AZN
$253B
| $27.1K | ﹤0.01% |
400
| – | – |
|
322
Jazz Pharmaceuticals
JAZZ
$7.86B
| $26.8K | ﹤0.01% |
168
| – | – |
|
323
Sarepta Therapeutics
SRPT
$1.96B
| $25.8K | ﹤0.01% |
199
| – | – |
|
324
Donaldson
DCI
$9.44B
| $25.7K | ﹤0.01% |
436
| – | – |
|
325
Graco
GGG
$14.2B
| $24.4K | ﹤0.01% |
363
| – | – |
|